New therapies for hemophilia: Options and assays project
Expires January 19, 2023
Video length: 26 minutes
In this month’s “Virtual Lecture,” Rajiv Pruthi, M.B.B.S., will discuss the evolution of therapy options for bleeding disorders, including hemophilia, current therapies for the management of hemophilia, and the impact on hemophilia centers and coagulation laboratories.
Upon completion of this program, participants should be able to:
- Explain the evolution of options bleeding disorder therapy.
- List the currently available options for management of hemophilia.
- Describe the impact on hemophilia centers and coagulation laboratories.
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
Associate Professor of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
The following types of credit are offered for this program:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 0.5 P.A.C.E.® contact hours.
To obtain credit:
- Watch the video.
- Complete the post-test and evaluation that launches immediately following the video.
- Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: firstname.lastname@example.org